TickerFacts.

20/20 Biolabs, Inc. (AIDX): Total Assets

Annual figures by period end, from SEC filings.

$4.14M
As of 2025-12-31
$6.12M
As of 2026-06-30
2024-12-31: $3.58M2025-12-31: $4.14M$4.14M
2024-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$4.14M+15.4%2026-03-31, Balance as of period end
2024-12-31$3.58Mn/a2026-03-31, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
20/20 Biolabs, Inc. (AIDX)2025-12-31$4.14M+15.4%
NeoGenomics Inc (NEO)2025-12-31$1.36B-17.0%
UL Solutions Inc. (ULS)2025-12-31$2.92B+4.3%
Hypha Labs, Inc. (FUNI)2025-09-30$409.2K-17.1%

Compare AIDX, NEO, ULS, FUNI side by side · Screen every company in Services-Testing Laboratories ↗